Literature DB >> 11441100

Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion.

J Wang1, E G Brooks, K B Bamford, T L Denning, J Pappo, P B Ernst.   

Abstract

The majority of humans infected with Helicobacter pylori maintain a lifelong infection with strains bearing the cag pathogenicity island (PAI). H. pylori inhibits T cell responses and evades immunity so the mechanism by which infection impairs responsiveness was investigated. H. pylori caused apoptotic T cell death, whereas Campylobacter jejuni did not. The induction of apoptosis by H. pylori was blocked by an anti-Fas Ab (ZB4) or a caspase 8 inhibitor. In addition, a T cell line with the Fas rendered nonfunctional by a frame shift mutation was resistant to H. pylori-induced death. H. pylori strains bearing the cag PAI preferentially induced the expression of Fas ligand (FasL) on T cells and T cell death, whereas isogenic mutants lacking these genes did not. Inhibiting protein synthesis blocked FasL expression and apoptosis of T cells. Preventing the cleavage of FasL with a metalloproteinase inhibitor increased H. pylori-mediated killing. Thus, H. pylori induced apoptosis in Fas-bearing T cells through the induction of FasL expression. Moreover, this effect was linked to bacterial products encoded by the cag PAI, suggesting that persistent infection with this strain may be favored through the negative selection of T cells encountering specific H. pylori Ags.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441100     DOI: 10.4049/jimmunol.167.2.926

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Helicobacter pylori.

Authors:  H Eguchi; S F Moss
Journal:  Mol Pathol       Date:  2002-10

2.  Oral vaccination against Helicobacter pylori infection is not effective in mice with Fas ligand deficiency.

Authors:  Yaron Avitzur; Esther Galindo-Mata; Nicola L Jones
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

3.  Expression of Helicobacter pylori AlpA protein and its immunogenicity.

Authors:  Jing Xue; Yang Bai; Ye Chen; Ji-De Wang; Zhao-Shan Zhang; Ya-Li Zhang; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

4.  Outsmarting the host: bacteria modulating the immune response.

Authors:  Matthew D Woolard; Jeffrey A Frelinger
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 5.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

6.  Antimicrobial effects of antioxidants with and without clarithromycin on Helicobacter pylori.

Authors:  Archana Chatterjee; Debasis Bagchi; Taharat Yasmin; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

7.  Selective induction of tumor necrosis receptor factor 6/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cells.

Authors:  Sunghee Kim; William J McAuliffe; Liubov S Zaritskaya; Paul A Moore; Lurong Zhang; Bernardetta Nardelli
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Helicobacter pylori disrupts STAT1-mediated gamma interferon-induced signal transduction in epithelial cells.

Authors:  David J Mitchell; Hien Q Huynh; Peter J M Ceponis; Nicola L Jones; Philip M Sherman
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway.

Authors:  Rena J Menaker; Peter J M Ceponis; Nicola L Jones
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori.

Authors:  Katharina Kranzer; Alexander Eckhardt; Michael Aigner; Gertrud Knoll; Ludwig Deml; Cornelia Speth; Norbert Lehn; Michael Rehli; Wulf Schneider-Brachert
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.